Da Yao Zhao
Vorstandsvorsitzender bei Youhe Medical Technology (Beijing) Co. Ltd.
Profil
Da Yao Zhao is currently the Chief Executive Officer at Youhe Medical Technology (Beijing) Co. Ltd.
and also holds the position of Director at HEC Pharm Co., Ltd.
In the past, Zhao worked as an Independent Non-Executive Director at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
from 2019 to 2022 and as a Vice President at Genzyme Corp.
Zhao received an undergraduate degree from Harvard Medical School.
Aktive Positionen von Da Yao Zhao
| Unternehmen | Position | Beginn |
|---|---|---|
Youhe Medical Technology (Beijing) Co. Ltd.
 Youhe Medical Technology (Beijing) Co. Ltd. BiotechnologyHealth Technology Part of Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Youhe Medical Technology (Beijing) Co. Ltd. is a biotechnology company based in Beijing, China. The Chinese company specializes in developing innovative antibody drugs with independent intellectual property rights. The CEO of the company is Da Yao Zhao. Youhe Medical Technology (Beijing) Co. was acquired by Biocytogen Pharmaceuticals (Beijing) Co., Ltd. on August 31, 2020. | Vorstandsvorsitzender | - |
HEC Pharm Co., Ltd.
 HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Da Yao Zhao
| Unternehmen | Position | Ende |
|---|---|---|
| YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 20.09.2022 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Da Yao Zhao
| Harvard Medical School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
HEC Pharm Co., Ltd.
HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Health Technology |
Youhe Medical Technology (Beijing) Co. Ltd.
Youhe Medical Technology (Beijing) Co. Ltd. BiotechnologyHealth Technology Part of Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Youhe Medical Technology (Beijing) Co. Ltd. is a biotechnology company based in Beijing, China. The Chinese company specializes in developing innovative antibody drugs with independent intellectual property rights. The CEO of the company is Da Yao Zhao. Youhe Medical Technology (Beijing) Co. was acquired by Biocytogen Pharmaceuticals (Beijing) Co., Ltd. on August 31, 2020. | Health Technology |